영구치 치수 기질세포를 이용한 연골 분화 및 분화 시기에 따른 형태학적 변화

정주령,김하나,박열,김민정,오영주,신수정,최윤정,김경호 大韓齒科保存學會 2012 Restorative Dentistry & Endodontics Vol.37 No.1

Objectives: The aim was to confirm the stem cell-like properties of the dental pulp stromal cells and to evaluate the morphologic changes during in vitro chondrogenesis. Materials and Methods: Stromal cells were outgrown from the dental pulp tissue of the premolars. Surface markers were investigated and cell proliferation rate was compared to other mesenchymal stem cells. Multipotency of the pulp cells was confirmed by inducing osteogenesis, adipogenesis and chondrogenesis. The morphologic changes in the chondrogenic pellet during the 21 day of induction were evaluated under light microscope and transmission electron microscope. TUNEL assay was used to evaluate apoptosis within the chondrogenic pellets. Results: Pulp cells were CD90, 105 positive and CD31, 34 negative. They showed similar proliferation rate to other stem cells. Pulp cells differentiated to osteogenic, adipogenic and chondrogenic tissues. During chondrogenesis, 3-dimensional pellet was created with multi-layers, hypertrophic chondrocyte-like cells and cartilage-like extracellular matrix. However, cell morphology became irregular and apoptotic cells were increased after 7 day of chondrogenic induction. Conclusions: Pulp cells indicated mesenchymal stem cell-like characteristics. During the in vitro chondrogenesis, cellular activity was superior during the earlier phase (within 7 day) of differentiation.

한국인의 급성 골수성 백혈병 및 골수 이형성 증후군과 HLA 연관성

윤정숙,김원일,한경자,김용구,임지향,민우성,김춘추 대한조혈모세포이식학회 2000 대한조혈모세포이식학회지 Vol.5 No.1

배경:주조직 적합항원 복합체(Major Histocompatibility Complex : MHC)는 쥐에서 처음 이식 항원으로 발견된 이래 이식 면역 분야에서 광범위하게 연구되어 왔으며, 면역 반응을 조절하는 주요 유전자로서 감염, 종양, 자가면역 질환 등의 발생에 관여한다. 사람에서 자가 면역 질환과 HLA 연관성이 증명되어 있으나, 백혈병에서 HLA 연관성에 관한 연구는 드물며 대상군 수가 유의한 결론을 얻기에 부족하다. 본 연구에서는 급성 골수성 백혈병(AML)과 골수 이형성 증후군(MDS) 환자를 대상으로 HLA class I, II 항원 및 2-유전자좌 일배체형 빈도를 구하고, 이를 정상 대조군과 비교하는 통계적 방법으로 AML 및 MDS군과 연관된 HLA 항원 및 일배체형이 있는지 살펴보고, AML군은 FAB 분류와 면역 표현형 분류에 따른 아군으로 분류하여 각 아군과 연관된 HLA 항원 및 일배체형을 관찰함으로써 AML 및 MDS군과 HLA의 연관성을 규명해 보고자 하였다. 방법:1991년 1월부터 1998년 7월까지 성모병원에 내원하여 NIH standard microlymphocytotoxicity를 이용한 혈청학적 방법으로 HLA class I, II 항원 형별 검사를 실시한 415례의 AML과 62례의 MDS 환자를 대상으로 하여 각 질환군과 FAB, 면역 표현형 아군에서 HLA 항원 빈도와 유전자 빈도를 구하고, 항원 빈도를 대조군과 비교하여 Haldane’s method에 따라 상대 위험도(RR)를 구한 뒤 chi-square 법으로 유의성을 검증하였다. AML, MDS 각 질환군과 아군에서 square root법을 이용하여 HLA A-B, C-B, B-DR 2-유전자좌 일배체형 빈도를 구하고, 이를 대조군과 비교하여 chi-square 법으로 유의성을 검증하였다. 결과:1) Cw8이 AML, MDS 질환군에서 RR이 0.10, 0.22로 매우 감소하여 이들 질환과 강한 연관성 정도를 나타냈다(p<0.001). 2) Blank 유전자 빈도의 증가가 AML, MDS 질환군의 각 HLA locus에서 관찰되었으며, 특히 이 분석 결과는 DR locus에서 현저하여, AML과 MDS군에서 DR-blank 빈도는 11.6%, 7.0%로 매우 증가하였다. 3)AML군과 A2-B61, Cw8-B61, B62-DR11 일배체형 연관성과, MDS군과 Cw3-B51, B62-DR14, B35-DR9 일배체형 연관성이 관찰되었다. 4)FAB 분류별 아군에서 AML-M3와 A33 항원 연관성과 AML-M1과 A2-B51 일배체형 연관성이 높은 통계적 유의성을 나타내었다(p<0.001). 5) AML 면역 표현형 아군에서 HLA-A29, B56 항원과 panmyeloid 면역 표현형인 CD33, CD15와의 연관성이 관찰되었고, A2-B48, Cw7-B44 일배체형과 myeloid 면역 표현형인 CD34, CD33, CD11c와의 연관성이 관찰되었다. 결론:AML과 MDS는 HLA와 연관성 있는 질환이며, AML과 MDS군의 발생 및 AML군에서 백혈병 세포의 분화 단계를 예측하기 위해 본 연구 자료가 유용할 것으로 생각된다. Background:The Major Histocompatibility Complex (MHC) has been widely studied in the field of transplantation immunology, since initially defined as transplantation antigen in mouse in 1936. Although associations have been demonstrated between many autoimmune diseases and HLA in human, the studies of HLA association with human leukemia are rare, and have too small sample size to get a significant result. We tried to invesgate the association of AML and MDS with HLA, and the association of FAB, immunological subgroup with HLA in AML group by using appropriate statistical methods. The purpose of this study is to elucidate the HLA role in the development of AML and MDS, and find any HLA antigens or haplotypes which can predict the development of AML or MDS. Methods: The subject of this study was 415 patients with AML and 62 patients with MDS who admitted in St. Mary's hospital between 1991. 1. and 1998. 7., and were typed for HLA class I, II antigens by using serological method of NIH standard microlymphocytotoxicity. We calculated the HLA antigen, gene and 2-locus haplotype frequencies in AML and MDS group and FAB, immunological subgroup, calculated relative risk by Haldane's method by comparing HLA antigen frequencies in disease group with those in normal control population. The Chi-Square method or Fisher's exact test was used to assess the significance of the differencies in the antigen and haplogtype distributions in the control vs disease population. Results: 1)The frequencies of Cw8 were severely decreased in AML and MDS population with relative risk of 0.10, 0.22, and revealed high statistical significance with p-values less than 0.001, suggesting strong Cw8 association with AML and MDS. This means Cw8 may be a gene which resists to the development of AML and MDS, or may be linked to other recessive gene, Cw8 may be a gene which encodes increased immune responses to exogenous antigens such as leukemia virus, or may be linked to other immune response gene, otherwise, Cw8 may be an antigen which has a key role in immune surveillance to the development of AML or MDS. 2) Blank gene frequencies were increased in AML and MDS group, and this phenomenon was prominent in DR locus, showing 11.6% and 7.0% of DR-blank gene frequencies in AML and MDS. This suggests increased HLA homozygosity or increased undetected antigens due to loss or modification of HLA alleles in AML and MDS. 3) The associations of A2-B61, Cw8-B61, B62-DR11 haplotypes with AML, and A30-B14, Cw3-B51, B62-DR14, B35-DR9 haplotypes with MDS were observed. 4) According to FAB classification in AML, highly significant HLA-A33 antigen association with AML-M3 and A2-B51 haplotype association with AML-M1 were observed. 5) According to immunological classification in AML, HLA-A29, B56 each antigen association with CD33, CD15, panmyeloid immunophenotypes and A2-B48, Cw7-B44 each haplotype association with CD34, CD33, CD11c, myeloid immunophenotypes were observed. Conclusion:AML and MDS is a disease associated with HLA, and this study will be valuable in predicting the development of AML and MDS, differentiation stages of leukemic cells in AML.

CD34+ 조혈 모세포 이식 2례

김정아,정현식,김원석,윤성수,이홍기,박찬형,박성규,김동욱,이종욱,한치화,민우성,김춘추,김동집 대한조혈모세포이식학회 1996 대한조혈모세포이식학회지 Vol.1 No.1

Background: In most solid tumors, the CD34 antigen has not been detected, so positive selection of CD34+ cells may reduce tumor cell contamination and the CD34+ cells are capable of reconstituting hematopoiesis. We tried CD34+ cell transplantation in two patients. Method: CD34+ cells from chemotherapy + G-CSF mobilized PBPCs or bone marrow were positively selected with an avidin-biotin immunoadsorption column (CEPRATE SC system). Case 1. One course of chemotherapy using cyclophosphamide(200㎎/㎡) and etoposide (4.2g/㎡), combined with G-CSF(5㎍/㎏) S.C. was used in a relapsed lymphoma patient. This patient responded to the induction chemotherapy. CD34+ cells from harvested bone marrow were selected by the CellPro immunoadsorption column. The total number of mononuclear cells loaded onto the CellPro was 2.4×10^(8)/㎏, with 1.1% CD34+ cells. After column separation, the total number of positively selected cells was 5.16×10^(6)/㎏. The number of CFU-GM was 76.8×10⁴/㎏. This patient was treated with melphalan (140㎎/㎡) and TBI (1200cGy) and the positively selected CD34+ cells were infused. The time to neutrophil recovery greater than 0.5×10^(9)/L was 19 days and the time to platelet recovery greater than 50×10^(9)/L was 21 days. Case 2. Two courses of mobilizing chemotherapy were given 4 weeks apart using taxol(210㎎/m2) and adriamycin(60㎎/m2), combined with G-CSF(5㎍/㎏) S.C. in a breast cancer patients with 7 axillary node metastasis. CD34+ cells from each single leukapheresis product were selected by the CellPro immunoadsorption column. In the first collection, the total number of nucleated cells was 4.4×10^(8)/kg, with 0.42% CD34+ cells. In the second collection, the total number of nucleated cell was 2.8× 10^(8)/㎏ with 0.43% CD34+ cells. After colum separation, the total numbers of collected cells were 4.0×106/kg and 4.8×10^(6)/kg, the total number of CD34+ cells were 1.2×10^(6)/㎏ and 0.82×10^(6)/㎏. Colonogenic assays of positively selected CD34+ cells gave rise to myeloid erythroid, and multilineage colonies, with a median of 190 CFU-GM, 190 BFU-E, and 164 CFU-GEMM per 1×10³ adsorbed cells, respectively. High-dose chemotherapy with cumulative doses of 40mg/㎡ mitoxantrone, 750mg/㎡ thioptepa, and 1000mg/㎡ carboplatin was administered. Positively selected CD34+ cells were rapidly infused 24 hours after the end of high-dose chemotherapy. The time to neutrophil recovery greater than 0.5×10^(9)/L was 16 days and the time to platelet recovery greater than 50×10^(9)/L was 20 days.

Anti-idiotypic 항체가 Hybridoma 세포의 Anti-DNA 항체 합성을 조절하는 기전

박선,박정수,김형일,주민경,장영주,윤정구,김영태 아주대학교 의과학연구소 1996 아주의학 Vol.1 No.1

The regulatory mechanism of anti-idiotypic antibody(anti-id Ab) in the immune response is not fully understood. It has been reported that anti-id Ab suppresses Ab production of lymphocytes or hybridoma cells in vitro, but it does not affect the proliferation of cells or Ab secretion. We investigated whether or not polyclonal anti-id Ab regulates the production of anti-DNA Ab(lgG2a) in hybridoma cells. In addition, the effects of anti-id Ab on the proliferation of cells and on the transcription levels of lg genes were studied to elucidate the cellular and molecular mechanisms for regulation of anti-DNA Ab production in hybridoma cells. The treatment of hybridoma cells with anti-id Ab resulted in an increase in the number of cells producing anti-DNA Ab. However, there was no significant difference in the proliferation rate and mRNA levels of Ig genes between hybridoma cells treated with anti-id Ab, and those treated with normal rabbit serum. These results and our previous data suggest that the number of hybridoma cells producing anti-DNA Ab by anti-id Ab is not directly related with the rate of proliferation of the cells. Furthermore, it appears that the number of hybridoma cells producing IgG class anti-DNA Ab is increased by anti-id Ab, whereas the number of hybridoma cells producing IgM class anti-DNA Ab is down-regulated by anti-id Ab.

G-CSF로 체내 증폭된 골수를 이용한 동종 조혈모세포이식

이종욱,김정아,민창기,김희제,엄현석,박수정,서정곤,김동욱,홍영선,민우성,김춘추,김동집 대한조혈모세포이식학회 1998 대한조혈모세포이식학회지 Vol.3 No.2

연구배경: 이식시 주입되는 골수세포수는 생착 속도 및 생존율과 밀접한 관계가 있으나, 임상적으로 환자의 체중이 공여자에 비해 지나치게 많을 때 단위 체중당 환자에게 주입되는 세포의 양이 적어 문제가 될 수 있다. 방법: 저자들은 가톨릭 조혈모세포이식 센터에서 동종 골수이식을 시행한 환자들 중 환자의 체중이 공여자에 비해 10kg이상 많은 경우 골수 채취 전에 공여자에게 3일간 피하로 G-CSF(10ug/kg/day)를 투여하여 골수를 체내(in vivo) 증폭시킨 후 골수이식을 시행한 25예의 환자를 대상으로 고식적인 방법으로 골수이식을 시행한 위험인자가 일치되는 대조군과 비교하여 이식된 세포수, 혈구의 회복속도 및 이식편대 숙주반응(GVHD)의 발생율, 그리고 생존율 등을 비교 분석하였다. 결과: 단기간의 G-CSF 투여로 증폭된 골수의 총 유핵세포수, 단핵구수는 대조군에 비해 3-5배, CD34 + 세포수는 6배 증폭되었으며, 두 군간에 세포의 면역표현형(CD4, CD5, CD7, CD8, CD20)의 차이는 없었다. 중성 백혈구 수가 0.5×10^(9)/L 이상 회복되는 시기는 두 군간의 차이가 없었으나(15.5일 vs 16일; p=0.131), 혈소판 수가 30×10^(9)/L 이상으로 회복되는 시기는 G-CSF 투여군에서 의의있게 단축되었다(20일 vs 26일; p=0.013). 두 군간 급성 및 만성 GVHD의 발생률과 정도의 차이는 없었으며, 이식 후 재발 및 생존율의 차이도 없었다. 결론: 이식전 공여자에게 단기간 G-CSF를 주사하여 생체내에서 골수 조혈모세포를 증폭시킨 후 이식하는 방법은 공여자와 환자의 심각한 체중 차이로 인해 단위체중당 이식되는 조혈모세포양이 부족한 환자들에게 안전하고 유용한 방법일 뿐만 아니라 GVHD의 증가 없이 빠른 혈구회복을 기대할 수 있는 이식기법이라고 생각한다. 향후 증폭된 골수 조혈모세포의 특성 연구 및 이의 효용성을 확인하기 위한 전향적인 연구가 필요하리라고 생각된다. Background: Sufficient stem cell doses are necessary to overcome engraftment failure in allogeneic bone marrow transplantation(BMT). Cell doses harvested may depend on body weight (BW) difference between donor and recipient. In practice, it is important to achieve large number of stem cells from donor who were lower BW than that of recipient. Methods: We have tried to inject G-CSF(10ug/kg/day) subcutaneously for 3 days to the allogeneic donor with lower BW than recipient before harvest to increase BM inoculum. BM was infused into patients without any manipulation on day 5. A total 25 patients were enrolled; 12 AML, 6 ALL, 5 SAA and 2 CML(expansion group). We compared the expansion group with 25 historical control patients, matched for diagnosis and clinical characteristics, who underwent unprimed BMT. Results: Recipient BW is not different between the expansion and control group. However, allogeneic donors in the control group weigh heavier than those in the expansion group. The yield of TNC, MNC, and CD34^(+) cells from G-CSFprimed BM was significantly higher than that from unprimed BM. There was no difference in immunophenotyping analysis(CD4, CD5, CD7, CD8, CD20) between two groups. The median time reaching to absolute neutrophil count more than 0.5×10^(9)/L was not different(15.5 vs 16 days: p=0.131), but time to platelet recovery more than 30×10^(9)/L was significantly shorter for the patients who received G-CSF-primed BM (20 vs 26 days: p=0.013). There was no difference in the incidence of acute and chronic GVHD, relapse rate and overall survival between the two groups with a median follow-up of 13 months. Conclusion: These data suggest that the short-term administration of G-CSF to an allogeneic donor prior to BM harvest seems to be a feasible method to achieve an adequate number of cell doses for patients who weigh higher than donors. Randomized, prospective study is needed to evaluate the efficacy of allogeneic BMT using in vivo expansion of BM by G-CSF.

정상면역을 가진 환자에서 발생한 복부대동맥의 진균 감염성동맥류 1예

이호영,김태형,추은주,전민혁,이은정,정은정,전성란,박의주,염욱,장원호,황정화,김동훈,김동원 대한감염학회 2008 감염과 화학요법 Vol.40 No.3

감염성동맥류는 드물지만, 치명적인 질환이다. 진성 진균성 감염성동맥류는 더 드물게 발생한다. 진균감염은 사망률과 이환율이 매우 높다. 그러나 증상이 비특이적이고 일반적인 진단방법으로는 민감하게 진단이 되지 않기 때문에 종종 진단이 어렵다. 저자들은 면역이 정상이고 다른 위험인자가 없는 환자에서 복부대동맥에 발생한 진균성 감염성동맥류를 경험하여 이를 보고한다. 컴퓨터 단층촬영과 혈관 수술에 기초하여 진단하였으며, 수술 후 조직배양에서 균이 동정되지는 않았으나 절제한 혈관조직에서 칸디다 감염을 시사하는 발아가 있는 효모균이 관찰되었다. 한국에서 1988년에서 2007년까지 복부에 발생한 감염성동맥류 17증례를 고찰하였을 때 진성 진균성 감염성동맥류는 없었으며, 저자들이 경험한 것이 복부에서 발생한 진균감염성 동맥류로는 첫 증례이다. Infected aneurysms are uncommon, frequently fatal lesions. "True" fungus-infected aneurysms are even rarer. Fungal infections have high morbidity and mortality. However, diagnosis is frequently difficult, since the symptoms are non-specific and standard diagnostic procedures are often insensitive. We experienced a patient with persistent fever and negative blood cultures. The patient was immunocompetent and had no risk factors, and was diagnosed with a fungus-infected aneurysm based on computed tomography and vascular surgery. The vascular tissue revealed some narrow-based budding yeast within the thrombus, suggesting Candida infection. Seventeen cases of infected aneurysm of the abdomen were reported in Korea from 1988 to 2007, although none were "true" fungus-infected aneurysms, making this the first fungus-infected aneurysm of the abdomen in Korea. Prompt diagnostic procedures and aggressive treatment modalities are necessary for patients with occult infection and negative blood cultures, regardless of their immunocompetence, because of the high morbidity and mortality of this condition.

동종 조혈모세포이식 후 발생한 크립토콕쿠스 척추염 1예

고윤호,임동준,이성수,조유경,이동건,최정현,김유진,민창기,김동욱,박정미,김춘추,신완식 대한감염학회 2001 감염 Vol.33 No.4

Skeletal cryptococcosis is an uncommon infection. Cryptococcus is a common cause of meningitis and infects 7∼10% of patients with AIDS. As well as AIDS, the infection may be seen in association with leukemia, lymphoma, Hodgkin's disease, sarcoidosis, tuberculosis and diabetes, also in patients on steroid medication. But there is no case report of skeletal cryptococcosis following allogeneic hematopoietic stem cell transplantation. A 40-year-old woman was admitted to the hospital because of low back pain. She had chronic myelogenous leukemia for 2 years and underwent allogeneic hematopoietic stem cell transplantation 8 months ago. She have been treated with steroid and cyclosporine orally because of chronic graft versus host disease. On examination she was afebrile and had posterior lower lumbar tenderness. But, she had no reduced strength of low extremities. Open biopsy was underwent. Histology demonstrated budding, round-to-oval, refractile yeast-like organisms within debris. The results of a lumbar puncture were unremarkable and cerebrospinal fluid culture failed to grow bacteria and yeast. The patient was treated with amphotericin B (1 gram) and AmBisome□ (2.8 gram) over 6 weeks. Three months after cessation of therapy, the patient was doing well.(Korean J Infect Dis 33:298∼301, 2001)

Clinical characteristics and oncologic outcomes in patients with preoperative clinical T3 and T4 colon cancer who were staged as pathologic T3

Jeong-Min Choo,Se-Jin Baek,Jung-Myun Kwak,Jin Kim,Seon-Hahn Kim 대한외과학회 2020 Annals of Surgical Treatment and Research(ASRT) Vol.99 No.1

Purpose: Clinically suspected T4 stage colon cancer from a preoperative exam is often diagnosed as T3 stage colon cancer pathologically after surgery, raising concerns about understaging. The aims of this study were to compare the survival of clinical T3 and T4 colon cancer patients who had received a pathologic T3 stage diagnosis postoperatively. Methods: Patients who were diagnosed with pathologic T3 stage colon cancer postoperatively were reviewed. Patients with clinically suspected T3 or T4 stage cancer on preoperative exam were enrolled in the study. We compared patient demographics and survival of the cT3 and cT4 groups. Results: Out of the 536 patients with pT3 colon cancer, 503 patients were cT3 (93.8%) and 33 patients were cT4 (6.2%) preoperatively. The most common reason for suspected clinical T4 stage cancer was free perforation (78.8%). There were no statistically significant differences between the 5-year overall survival and the total 5-year disease-free survival (DFS) between the cT3 and cT4 groups; however, local recurrence was significantly higher in the cT4 group (local 5-year DFS: 98.6% vs. 84.0%, P < 0.001). Multivariate analysis showed cT stage was associated with local recurrence, but the association was not statistically significant (P = 0.056). Conclusion: Preoperative clinically suspected T4 stage colon cancer showed inferior local recurrence despite a postoperative pathologic diagnosis of T3 stage cancer. It is necessary to address the shortcomings of pathologic exams in the matter of the understaging of T4 colon cancer, and to reinforce the treatment for local control in patients with cT4 colon cancer.

Korean Medication Algorithm for Depressive Disorder 2021, Fourth Revision: An Executive Summary

Jeong Seok Seo,박원명,Young Sup Woo,Young-Min Park,Won Kim,Jong Hyun Jeong,Se-Hoon Shim,Jung Goo Lee,Seung-Ho Jang,Chan-Mo Yang,Sheng Min Wang,Myung Hun Jung,Hyung Mo Sung,IL Han Choo,Bo-Hyun Yoon,이상열,전덕 대한정신약물학회 2021 CLINICAL PSYCHOPHARMACOLOGY AND NEUROSCIENCE Vol.19 No.4

Objective: In the 19 years since the Korean College of Neuropsychopharmacology and the Korean Society for Affective Disorders developed the Korean Medication Algorithm Project for Depressive Disorder (KMAP-DD) in 2002, four revisions have been conducted. Methods: To increase survey efficiency in this revision, to cover the general clinical practice, and to compare the results with previous KMAP-DD series, the overall structure of the questionnaire was maintained. The six sections of the questionnaire were as follows: 1) pharmacological treatment strategies for major depressive disorder (MDD) with/without psychotic features; 2) pharmacological treatment strategies for persistent depressive disorder and other depressive disorder subtypes; 3) consensus for treatment-resistant depression; 4) the choice of an antidepressant in the context of safety, adverse effects, and comorbid physical illnesses; 5) treatment strategies for special populations (children/adolescents, elderly, and women); and 6) non-pharmacological biological therapies. Recommended first-, second-, and third-line strategies were derived statistically. Results: There has been little change in the four years since KMAP-DD 2017 due to the lack of newly introduced drug or treatment strategies. However, shortened waiting time between the initial and subsequent treatments, increased preference for atypical antipsychotics (AAPs), especially aripiprazole, and combination strategies with AAPs yield an active and somewhat aggressive treatment trend in Korea. Conclusion: We expect KMAP-DD to provide clinicians with useful information about the specific strategies and medications appropriate for treating patients with MDD by bridging the gap between clinical real practice and the evidence- based world.

프로필렌 옥사이드를 부가한 소듐 라우레스 설페이트 음이온 계면활성제의 계면 특성에 관한 연구

이정민 ( Jeong Min Lee ),박기호 ( Ki Ho Park ),신희동 ( Hee Dong Shin ),정우진 ( Woo Jin Jeong ),임종주 ( Jong Choo Lim ) 한국공업화학회 2023 공업화학 Vol.34 No.3

본 연구에서는 라우릴 알코올에 에틸렌 옥사이드 3 몰과 프로필렌 옥사이드 1 몰을 부가한 후 설페이션을 공정을 거쳐서 ASCO^Ⓡ SLES-430을 제조하였으며, 합성한 계면활성제의 구조를 FT-IR, ¹H-NMR 및 ¹³C-NMR 분석을 통하여 확인하였다. 합성한 ASCO^Ⓡ SLES-430의 임게 마이셀 농도, 정적 표면장력, 유화력, 접촉각 등의 계면 물성과 경구 독성 및 피부 자극성 등의 안정성 지표 등을 측정하였으며, SLES 계면활성제 내에 에틸렌 옥사이드가 각각 2 몰 및 3 몰 부가된 ASCO^Ⓡ SLES-226 및 ASCO^Ⓡ SLES-328 계면활성제들과 비교하였다. 특히, ASCO^Ⓡ SLES-430의 기포 생성력과 기포 안정성을 평가하여 기존 세제 제품에서 널리 사용되고 있는 ASCO^Ⓡ SLES-226과 ASCO^Ⓡ SLES-328과 비교함으로써 ASCO^Ⓡ SLES-430의 소형 빌트인 세탁기용 세제 적용 가능성을 검토하였다. In this study, ASCO^Ⓡ SLES-430 surfactant was synthesized by adducting 3 moles of ethylene oxide and 1 mole of propylene oxide to lauryl alcohol followed by a sulfation process, and the structure of the synthesized ASCO^Ⓡ SLES-430 was elucidated by performing FT-IR, ¹H-NMR and ¹³C-NMR analyses. Interfacial properties such as critical micelle concentration, static surface tension, emulsification index, and contact angle were measured, and environmental compatibility indices such as oral toxicity and skin irritation were also estimated for ASCO^Ⓡ SLES-430. Both results were compared with ASCO^Ⓡ SLES-226 and ASCO^Ⓡ SLES-328 SLES surfactants possessing 2 moles and 3 moles of ethylene oxide, respectively. In particular, both foaming ability and foam stability were evaluated for ASCO^Ⓡ SLES-430 and compared with ASCO^Ⓡ SLES-226 and ASCO^Ⓡ SLES-328, which have been widely used in detergent products, in order to test the potential applicability of ASCO^Ⓡ SLES-430 in detergent product formulation for a small capacity built-in washing machine.